Pulse Biosciences Inc (DE) (PLSE) Financials

$49.61

$-5.59 (-10.13%)

As on 16-Sep-2026 16:21EDT

Market cap

$3,788 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

38.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1.19	0.35	--	-0.01	0.70	1.42
Cost of Revenue	1.44	1.61	1.18	1.21	11.94	1.97
Gross Profit	-0.26	-1.26	-1.18	-1.21	-11.24	-0.55
Operating Expenses	82.79	75.68	56.26	42.37	46.81	62.46
Operating Profit (EBIT)	-83.04	-76.94	-56.26	-43.57	-58.06	-63.01
Other Income	--	--	--	--	--	--
Profit before Tax	-80.06	-72.78	-53.59	-42.21	-58.51	-63.66
Provision for Tax	--	--	-53.59	--	0.45	-0.50
Profit after Tax (Net Income)	-80.06	-72.78	-53.59	-42.21	-58.95	-63.16
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-63.66

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	99.50	80.66	114.86	44.36	-2.25	35.69
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	5.09	7.54	7.54	8.09	74.14	10.04
Current Liabilities	10.98	7.92	10.06	6.71	5.98	8.52
Total Liabilities	126.54	96.11	132.46	59.15	77.88	54.25

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	9.86	12.69	13.01	13.83	15.73	17.62
Current Assets	105.70	83.42	119.45	45.33	62.15	36.63
Total Assets	126.54	96.11	132.46	59.15	77.88	54.25
Total Debt*	6.77	7.53	8.90	9.14	75.96	11.25
Net Current Assets	94.72	75.50	109.39	38.62	56.17	28.11

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-54.12	-36.34	-33.04	-47.01	-54.10
Cash Flow from Investing Activities	--	-0.34	-0.13	-0.12	-0.40	7.56
Cash from Financing Activities	--	17.15	110.14	16.39	79.94	62.69
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.18	-1.08	-0.92	-0.77	-1.58	-2.13
Cash EPS ($)	--	-1.06	-0.90	-0.74	-1.55	-2.09
Adjusted Book Value ($)	--	1.20	1.97	0.81	--	1.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.80	-0.62	-0.60	-1.26	-1.83
Free Cash Flow per Share ($)	--	-0.81	-0.62	-0.60	-1.27	-1.84

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-68.68	-60.46	-66.36	-97.73	-155.59
ROE (%)	-88.87	-74.45	-67.31	-200.47	-352.57	-215.62
ROA (%)	-62.60	-63.68	-55.93	-61.61	-89.24	-132.21
EBIT Margin (%)	-4,723.04	-20,794.57	--	456,777.78	-8,293.86	-4,443.86
Net Margin (%)	-6,755.78	-20,794.57	--	469,000.00	-8,421.86	-4,454.16
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-52.52	--	1.00	-1.01	-0.51	11.44
EBIT Growth (%)	17.73	-35.82	-30.35	29.19	7.87	-26.12
Net Profit Growth (%)	-17.68	-35.82	-26.95	28.40	6.66	-26.99
EPS Growth (%)	-9.50	-0.18	-0.20	0.52	0.26	-0.09
Book Value Growth (%)	-7.42	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-12.71	-18.97	-15.97	-1.75	-6.95
Price / Book Value	38.07	11.47	8.85	15.19	-45.87	12.30
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.81	-11.88	-17.32	-16.01	-2.08	-6.81
Close Price ($)	27.73	13.73	17.41	12.24	2.77	14.81
High Price ($)	31.00	25.00	22.69	13.62	15.38	45.82
Low Price ($)	12.56	12.56	6.60	2.36	1.18	14.11
Market Cap ($ Cr)	3,787.94	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.09	0.08	0.21	-33.79	0.32
Short term debt to equity ratio	0.02	0.02	0.01	0.02	-0.81	0.03
Current Ratio	9.63	10.53	11.88	6.76	10.39	4.30
Quick Ratio	9.61	10.51	11.88	--	10.39	3.62
Interest Coverage	--	--	--	-37.37	-129.59	-97.54

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	10.30	78.29	--	--	--	4.30
Asset Turnover	0.01	0.00	--	0.00	0.01	0.03
Receivable days	--	142.97	--	--	15.91	7.86
Inventory Days	--	15.43	--	--	89.05	540.45
Payable days	--	504.77	544.00	515.80	68.45	428.82
Cash Conversion Cycle	--	-346.37	--	-515.80	36.51	119.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.